Yuanguang Group possesses 51 researchers, including 3 academicians, 16 experts and professors, and 32 doctoral supervisors. It is a R&D and production base for new biomedical materials and polypeptide pharmaceuticals, and also a national public service platform for R&D and analysis of polypeptide and new biomedical materials.
It makes great efforts in the development of polypeptide pharmaceuticals, innovative pharmaceuticals, new biological materials pharmaceuticals, anti-cardiovascular pharmaceuticals, anti-tumor pharmaceuticals, metabolic pharmaceuticals, anti-infectious pharmaceuticals.